Ablexis grants rights for Adimab to internalize select strains of the AlivaMab® Mouse platform for antibody drug discovery for its clientsSAN DIEGO (BUSINESS WIRE) Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license agr.